Utilization of Immediate Postpartum Long Acting Reversible Contraceptives among Women Who Gave Birth in Public Health Facilities in Eastern Ethiopia: A Cross-Sectional Study.
Journal
International journal of reproductive medicine
ISSN: 2356-7104
Titre abrégé: Int J Reprod Med
Pays: Egypt
ID NLM: 101633172
Informations de publication
Date de publication:
2021
2021
Historique:
received:
27
08
2021
accepted:
02
11
2021
entrez:
22
11
2021
pubmed:
23
11
2021
medline:
23
11
2021
Statut:
epublish
Résumé
Although importance of postpartum family planning is essential and immediate postpartum insertion of long acting and reversible contraceptives (LARC) is recommended, evidence on its uptake and associated factors is limited in Ethiopia. This study was conducted to assess utilization of immediate postpartum LARC among women who gave birth in selected public health facilities in eastern Ethiopia. An institution-based cross-sectional study was conducted among randomly selected women who gave birth in selected public health facilities in eastern Ethiopia from 10 March to 09 April 2020. At discharge, all eligible women who gave birth in the facilities were interviewed using a pretested structured questionnaire. Data were entered using EpiData 3.1 and analyzed using SPSS 24. Bivariable and multivariable logistic regression analyses were conducted to identify factors associated with utilization of immediate postpartum LARC. Adjusted odds ratio (aOR) with 95% confidence interval was used to report association, and significance was declared at From a total of 546 women invited to the study, 530 (97.1%) participated in the study and 98 (18.5%; 95% CI: 15.1%, 22.0%) reported starting long acting reversible contraceptives. Women who reported discussing about contraceptives with partners (aOR = 6.69, 95% CI: 3.54, 12.61) and receiving postpartum counselling on contraceptives (aOR = 5.37, 95% CI: 3.00, 9.63) were more likely to using contraception. However, women who live >30-minute walking distance from the nearest health facility (aOR = 0.47, 95% CI: 0.26, 0.85) and reported disrespect and abuse during childbirth (aOR = 0.22, 95% CI: 0.12, 0.40) were less likely to start LARC. Almost one in five women delivering in public health facilities in eastern Ethiopia started using LARC. Provision of respectful maternity care including counselling on the importance of immediate postpartum family planning is essential for increasing its uptake.
Identifiants
pubmed: 34805394
doi: 10.1155/2021/1307305
pmc: PMC8598333
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1307305Informations de copyright
Copyright © 2021 Ahmedin Aliyi Usso et al.
Déclaration de conflit d'intérêts
The authors declare that there is no conflict of interest.
Références
BMC Res Notes. 2015 Feb 04;8:29
pubmed: 25656470
Reprod Health. 2012 Jan 12;9:1
pubmed: 22239744
Reprod Health. 2015;12 Suppl 2:S11
pubmed: 26063346
Lancet Glob Health. 2019 Jun;7(6):e710-e720
pubmed: 31097275
Contraception. 2014 Sep;90(3):259-64
pubmed: 24993485
J Am Acad Child Adolesc Psychiatry. 2014 Oct;53(10):1074-81.e4
pubmed: 25245351
Matern Child Health J. 2017 Sep;21(9):1744-1752
pubmed: 27562799
BMC Pregnancy Childbirth. 2012 Jan 26;12:6
pubmed: 22280163
Int J Gynaecol Obstet. 2015 Oct;131 Suppl 1:S60-3
pubmed: 26433510
Matern Child Health J. 2015 Oct;19(10):2243-50
pubmed: 25990843
Contraception. 2008 Jul;78(1):73-8
pubmed: 18555821
Stud Fam Plann. 2013 Dec;44(4):445-59
pubmed: 24323662
Pan Afr Med J. 2017 Nov 10;28:222
pubmed: 29629008
BMC Res Notes. 2018 Sep 17;11(1):671
pubmed: 30223872
BMC Womens Health. 2015 Aug 19;15:62
pubmed: 26285582
Epidemiology. 2013 Nov;24(6):906-12
pubmed: 24045716
Int J Environ Res Public Health. 2019 May 01;16(9):
pubmed: 31052372
Obstet Gynecol. 2016 Aug;128(2):e32-7
pubmed: 27454734
Reprod Health. 2015 Aug 27;12:76
pubmed: 26311141
Stud Fam Plann. 2010 Dec;41(4):241-50
pubmed: 21465725
Contracept Reprod Med. 2018 Nov 6;3:16
pubmed: 30410787
Lancet Glob Health. 2020 Sep;8(9):e1152-e1161
pubmed: 32710833
Matern Health Neonatol Perinatol. 2017 Dec 22;3:24
pubmed: 29299334